Skip to content

ESD Home

TechCentury

Powered by

Engineering Society of Detroit Lawrence Technological University

Tag: U.S. Food and Drug Administration

Cancer Diagnosis and Treatment / Clinical Trials / Medical Devices / Ultrasound Technology

Ann Arbor firm gets OK for trial of new liver tumor treatment

ANN ARBOR—HistoSonics Inc. announced that it had received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin a clinical trial of its new technology, …

Pharmaceuticals

Esperion Moving Ahead With Cholesterol-Buster

ANN ARBOR — The pharmaceutical startup Esperion Therapeutics Inc. (NASDAQ: ESPR) said it’s moving toward Phase 3 clinical testing of its leading drug candidate, ETC-1002, or bempedoic acid. In Phase …

Read the magazine:

TechCentury
Advertise or Contribute an Article
Lawrence Technological University

Subscribe to TechCentury.com

Top Posts

  • Esperion expands licensing deal with Daiichi Sankyo Group
  • New walk-in van from Utilimaster
  • Liquid Web Bought Out By Chicago Firm; Founding CEO To Step Down
  • ESD Tours Guardian Glass Plant
  • Lear breaks ground on seating plant in Flint

Archives

Follow Us On

© The Engineering Society of Detroit   |   ABOUT